Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study

Background: The chronic kidney disease (CKD) population, including kidney transplant recipients (KTRs) and subjects on renal replacement therapy, is particularly vulnerable to unfavorable outcomes from chronic hepatitis C (CHC). Currently, there are oral direct-acting antiviral agents (DAAs) availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Paulina, Czarnecka, Kinga, Tronina, Olga, Bączkowska, Teresa, Wyczałkowska-Tomasik, Aleksandra, Durlik, Magdalena, Czerwinska, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219487/
https://www.ncbi.nlm.nih.gov/pubmed/37240622
http://dx.doi.org/10.3390/jcm12103513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219487/
https://www.ncbi.nlm.nih.gov/pubmed/37240622
http://dx.doi.org/10.3390/jcm12103513

Ejemplares similares